Jonah Comstock

Health tech journalist. Editor in Chief, pharmaphorum. Tweets are my own. Profile photos by @SOSKI_photo & @SFBIZronleuty

[Jonah Comstock @JonahComstock]

I have pretty much abandoned this platform for some time, but now I'm officially heading over to that other, cloudless one. I should be easy to find.

[Jonah Comstock @JonahComstock]

On the off-chance that this isn't muzzled, my social media coverage of #REpharmaUSA is happening elsewhere, where the skies are bluer....

[Jonah Comstock @JonahComstock]

The IRA prices are out and ... I guess the sky isn't falling? Savings for patients are significant, no one's going out of business, pharma's still not happy about the IRA. https://t.co/RyjXUUb5D1

[Jonah Comstock @JonahComstock]

@jeffjarvis I thought Clooney's editorial was full of empathy. I think a lot of the initial voices were like that -- "We love you Joe, we're thankful for all you've done, but it's time to go for the good of the party and the nation". That's a very empathetic way of sending the message.

[Jonah Comstock @JonahComstock]

My #BIO2024 live blog is now live! https://t.co/QRJsjc8iVk

[Jonah Comstock @JonahComstock]

I will be in Chicago this weekend for #ASCO and then San Diego next week for #BIO. My last work travel for a little while. Let me know about can't miss sessions and parties.

[Jonah Comstock @JonahComstock]

My liveblog coverage of FT's US Pharma and Biotech conference has begun: https://t.co/rucEzB8b9a

[Jonah Comstock @JonahComstock]

If you're looking to meet me out and about, the next month is your chance! I'll be at the @FT US Pharma and Biotech Summit on Thursday. Then at the end of the month I'm doing the ASCO-BIO double feature. So please reach out if you'll be in NYC, Chicago, or San Diego and say hi!

[Jonah Comstock @JonahComstock]

If your post-event survey has a free text field for a testimonial, it should also have a free text field for actual feedback.

[Jonah Comstock @JonahComstock]

Check out our Reuters Pharma USA live blog here: https://t.co/MdNXkO5OnT

[Jonah Comstock @JonahComstock]

One of the fun things about working at the intersection of pharma and tech is figuring out what people mean when they say "API" in any given instance.

I wonder if there's anyone building APIs to manage APIs and whether working there is like Abbot and Costello routine.

[Jonah Comstock @JonahComstock]

In fiery SOTU, Biden proclaims “We finally beat big pharma” https://t.co/cF6BIiqZ8t

[Jonah Comstock @JonahComstock]

@chrissyfarr And who's doing the work to separate meaningful results from the slick PR in this future? That seems like exactly journalists' job.

[Jonah Comstock @JonahComstock]

Hot off the presses -- Six takeaways from JP Morgan 2024: https://t.co/2AY4tgD1nu

[Jonah Comstock @JonahComstock]

Had a really great #jpm2024. I should probably have taken pictures with @naveen101, @amypuliafito, @boltyboy, and other old friends from my Mobi days. But just know it was lovely to see you all, even if briefly. Column and podcast coming soon with all my JPM-y thoughts.

[Jonah Comstock @JonahComstock]

@nickisnpdx @startuphealth @boltyboy @unitystoakes @jameyedwards @healthythinker @janemetcalfe @glfceo @RasuShrestha @VentureValkyrie @EvanKirstel @Lacktman I miss that show too!

[Jonah Comstock @JonahComstock]

This strikes me as a good one to watch for value-based pricing advocates -- if it's weighting that much in payer calculations that says a lot about the power of risk-sharing.

[Jonah Comstock @JonahComstock]

. @bluebirdbio's Andrew Obenshain tells @FierceHealth 's Angus Liu that insomuch as payers are signing up for their $3.1M sickle cell drug over @VertexPharma's $2.2M alternative, they're doing it because of bluebird's outcomes-based pricing. #jpm2024

[Jonah Comstock @JonahComstock]

I'm back for day 2 of liveblogging JPM side events. Kicked off with a great presentation from @DaiichiSankyoUS CEO Ken Keller. https://t.co/LcCLecLhxf

[Jonah Comstock @JonahComstock]

I have all but abandoned this platform, but I would love for you all to check out my JPM live blog: https://t.co/a5KjFOV3It